Oral topical cidofovir: Novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection

Transplant Infectious Disease

Volumn 9, Issue 3, 2007, Pages 256-259

  Sims, C R ^a   Thompson, K ^b   Chemaly, R F ^a   Shpall, E J ^a   Champlin, R E ^a   Safdar, A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cidofovir; Herpes simplex virus; Immunosuppressed; Multidrug resistant; Oral delivery

Indexed keywords

ACICLOVIR; BUSULFAN; CIDOFOVIR; FLUDARABINE; FOSCARNET;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CELL TRANSPLANTATION; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; LABORATORY TEST; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ANTIVIRAL AGENTS; CYTOSINE; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; MOUTHWASHES; PHOSPHONIC ACIDS; STEM CELL TRANSPLANTATION; STOMATITIS, HERPETIC;

EID: 34547788152     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00261.x     Document Type: Article

References (18)

1. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001 17: 531 571.
2. Morfin F, Bilger K, Boucher A, et al. HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol 2004 30: 341 345.
3. Stranska R, Schuurman R, Nienhuis E, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005 32: 7 18.
4. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004 42: 242 249.
5. Martinez CM, Luks-Golger DB. Cidofovir use in acyclovir-resistant herpes infection. Ann Pharmacother 1997 31: 1519 1521.
6. Thompson KD, Dragar C. Antiviral activity of Undaria pinnatifida against herpes simplex virus. Phytother Res 2004 18: 551 555.
7. Saijo M, Suzutani T, Morikawa S, Kurane I. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain. Antimicrob Agents Chemother 2005 49: 606 611.
8. Bestman-Smith J, Boivin G. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids. J Virol 2003 77: 7820 7829.
9. Englund JA, Zimmerman ME, Swierkosz EM, Goodman JL, Scholl DR, Balfour HH. Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med 1990 112: 416 422.
10. Gray JJ, Wreghitt TG, Baglin TP. Susceptibility to acyclovir of herpes simplex virus: emergence of resistence in patients with lymphoid and myeloid neoplasia. J Infect 1989 19: 31 40.
11. Wade JC, McLaren C, Meyers JD. Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J Infect Dis 1983 148: 1077 1082.
12. Chen Y, Scieux C, Garrait V, et al. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation. Clin Infect Dis 2000 31: 927 935.
13. Chakrabarti S, Pillay D, Ratcliffe D, Cane PA, Collingham KE, Milligan DW. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. J Infect Dis 2000 181: 2055 2058.
14. Langston AA, Redei I, Caliendo AM, et al. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. Blood 2002 99: 1085 1088.
15. Posavad CM, Huang ML, Barcy S, Koelle DM, Corey L. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes. J Immunol 2000 165: 1146 1152.
16. Ortiz A, Justo P, Sanz A, et al. Tubular cell apoptosis and Cidofovir-induced acute renal failure. Antivir Ther 2005 10: 185 190.
17. Snoeck R, Andrei G, Gerard M, et al. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin Infect Dis 1994 18: 570 578.
18. Toutous-Trellu L, Hirschel B, Piguet V, Schiffer V, Saurat JH, Pechere M. Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients. Ann Dermatol Venereol 2004 131: 445 449.